title: Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C.
authors.forename: Takashi
authors.initials: T
authors.lastname: Honda
authors.forename: Hidenori
authors.initials: H
authors.lastname: Toyoda
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Hayashi
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Katano
authors.forename: Motoyoshi
authors.initials: M
authors.lastname: Yano
authors.forename: Isao
authors.initials: I
authors.lastname: Nakano
authors.forename: Kentaro
authors.initials: K
authors.lastname: Yoshioka
authors.forename: Hidemi
authors.initials: H
authors.lastname: Goto
authors.forename: Koji
authors.initials: K
authors.lastname: Yamamoto
authors.forename: Junki
authors.initials: J
authors.lastname: Takamatsu
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D001779:Blood Coagulation Factors; D012254:Ribavirin; D007372:Interferons